Send
Print
Kelonia shareholders will obtain $3.25 billion right away and up to $3.75 billion depending on the attainment of specific milestones.
The Wall Street Journal earlier covered the agreement, referencing knowledgeable sources.
Kelonia is creating groundbreaking gene-cell therapy solutions for blood cancer. In April 2022, it had a valuation of $100 million.
Eli Lilly has emerged as the world's most valuable pharmaceutical company due to the success of its weight-loss products. The market cap of the company is roughly $876 billion.
source: wsj.com
The Wall Street Journal earlier covered the agreement, referencing knowledgeable sources.
Kelonia is creating groundbreaking gene-cell therapy solutions for blood cancer. In April 2022, it had a valuation of $100 million.
Eli Lilly has emerged as the world's most valuable pharmaceutical company due to the success of its weight-loss products. The market cap of the company is roughly $876 billion.
source: wsj.com
